Andrea L. True

1.6k total citations
15 papers, 1.4k citations indexed

About

Andrea L. True is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Andrea L. True has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Infectious Diseases. Recurrent topics in Andrea L. True's work include NF-κB Signaling Pathways (5 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). Andrea L. True is often cited by papers focused on NF-κB Signaling Pathways (5 papers), HIV/AIDS drug development and treatment (4 papers) and HIV Research and Treatment (3 papers). Andrea L. True collaborates with scholars based in United States and Switzerland. Andrea L. True's co-authors include Asrar B. Malik, Arshad Rahman, Khandaker N. Anwar, Elizabeth G. Nabel, Manfred Boehm, Hong San, James L. Park, Gary J. Nabel, R. Clinton Webb and Mu-En Lee and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and The Journal of Immunology.

In The Last Decade

Andrea L. True

14 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea L. True United States 12 775 266 236 164 160 15 1.4k
Hakan Çamlıca Türkiye 22 510 0.7× 197 0.7× 197 0.8× 110 0.7× 100 0.6× 68 1.5k
Shi-Fang Yan United States 10 731 0.9× 332 1.2× 371 1.6× 138 0.8× 120 0.8× 10 1.6k
Takafumi Nakao Japan 18 498 0.6× 200 0.8× 120 0.5× 214 1.3× 149 0.9× 59 1.3k
Maki Urushihara Japan 29 590 0.8× 519 2.0× 87 0.4× 102 0.6× 101 0.6× 81 2.5k
Elisabeth I. Wallner United States 21 916 1.2× 302 1.1× 151 0.6× 90 0.5× 63 0.4× 43 1.8k
Sumant S. Chugh United States 21 777 1.0× 229 0.9× 126 0.5× 239 1.5× 63 0.4× 40 2.2k
Cristina Zanchi Italy 24 612 0.8× 331 1.2× 113 0.5× 162 1.0× 91 0.6× 30 2.1k
Tetsuro Okabe Japan 24 582 0.8× 245 0.9× 129 0.5× 104 0.6× 199 1.2× 73 1.5k
Christiane Viedt Germany 19 567 0.7× 600 2.3× 123 0.5× 80 0.5× 72 0.5× 22 1.9k
Zhanmei Zhou China 23 743 1.0× 175 0.7× 313 1.3× 146 0.9× 55 0.3× 46 1.6k

Countries citing papers authored by Andrea L. True

Since Specialization
Citations

This map shows the geographic impact of Andrea L. True's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea L. True with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea L. True more than expected).

Fields of papers citing papers by Andrea L. True

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea L. True. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea L. True. The network helps show where Andrea L. True may publish in the future.

Co-authorship network of co-authors of Andrea L. True

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea L. True. A scholar is included among the top collaborators of Andrea L. True based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea L. True. Andrea L. True is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Shalit, Peter, et al.. (2007). Quality of Life and Tolerability After Administration of Enfuvirtide with a Thin-Walled Needle: QUALITÉ Study. HIV Clinical Trials. 8(1). 24–35. 14 indexed citations
2.
True, Andrea L., Michelle Olive, Manfred Boehm, et al.. (2007). Heme Oxygenase-1 Deficiency Accelerates Formation of Arterial Thrombosis Through Oxidative Damage to the Endothelium, Which Is Rescued by Inhaled Carbon Monoxide. Circulation Research. 101(9). 893–901. 131 indexed citations
3.
Thompson, Melanie, Edwin DeJesus, Gary Richmond, et al.. (2006). Pharmacokinetics, pharmacodynamics and safety of once-daily versus twice-daily dosing with enfuvirtide in HIV-infected subjects. AIDS. 20(3). 397–404. 7 indexed citations
4.
Zhang, Ying, et al.. (2006). A Prospective Clinical and Pathological Examination of Injection Site Reactions with the HIV-1 Fusion Inhibitor Enfuvirtide. Antiviral Therapy. 11(7). 935–940. 9 indexed citations
5.
True, Andrea L., et al.. (2006). Pharmacokinetic Bioequivalence of Enfuvirtide Using a Needle‐Free Device versus Standard Needle Administration. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(12). 1679–1686. 11 indexed citations
6.
Boehm, Manfred, Michelle Olive, Andrea L. True, et al.. (2004). Bone marrow–derived immune cells regulate vascular disease through a p27Kip1-dependent mechanism. Journal of Clinical Investigation. 114(3). 419–426. 44 indexed citations
7.
Boehm, Manfred, Michelle Olive, Andrea L. True, et al.. (2004). Bone marrow–derived immune cells regulate vascular disease through a p27Kip1-dependent mechanism. Journal of Clinical Investigation. 114(3). 419–426. 43 indexed citations
8.
Rahman, Arshad, Khandaker N. Anwar, Mohd Minhajuddin, et al.. (2004). cAMP targeting of p38 MAP kinase inhibits thrombin-induced NF-κB activation and ICAM-1 expression in endothelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 287(5). L1017–L1024. 49 indexed citations
9.
Rahman, Arshad, Andrea L. True, Khandaker N. Anwar, et al.. (2002). q and Gβγ Regulate PAR-1 Signaling of Thrombin-Induced NF-κB Activation and ICAM-1 Transcription in Endothelial Cells. Circulation Research. 91(5). 398–405. 130 indexed citations
10.
Duckers, Henricus J., Manfred Boehm, Andrea L. True, et al.. (2001). Heme oxygenase-1 protects against vascular constriction and proliferation. Nature Medicine. 7(6). 693–698. 445 indexed citations
11.
Duckers, Henricus J., Manfred Boehm, Andrea L. True, et al.. (2001). Duckers, H.R. Heme oxygenase-1 protects against vascular constriction and proliferation. Nature Med. 7, 692-698.
12.
True, Andrea L., Arshad Rahman, & Asrar B. Malik. (2000). Activation of NF-κB induced by H2O2and TNF-α and its effects on ICAM-1 expression in endothelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 279(2). L302–L311. 122 indexed citations
13.
Rahman, Arshad, Khandaker N. Anwar, Andrea L. True, & Asrar B. Malik. (1999). Thrombin-Induced p65 Homodimer Binding to Downstream NF-κB Site of the Promoter Mediates Endothelial ICAM-1 Expression and Neutrophil Adhesion. The Journal of Immunology. 162(9). 5466–5476. 133 indexed citations
14.
Rahman, Arshad, Khandaker N. Anwar, Andrea L. True, & Asrar B. Malik. (1999). Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion.. PubMed. 162(9). 5466–76. 149 indexed citations
15.
Uhal, Bruce D., et al.. (1995). Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. American Journal of Physiology-Lung Cellular and Molecular Physiology. 269(6). L819–L828. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026